A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)
Clinical trial NCT01641926 · TERMINATED
Trial details
- NCT number
- NCT01641926
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-26
- Primary completion
- 2016-01-21
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.